{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T20:32:50Z","timestamp":1791059570811,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2010,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Lassa hemorrhagic fever (LHF) is a neglected tropical disease with significant impact on the health care system, society, and economy of Western and Central African nations where it is endemic. With a high rate of infection that may lead to morbidity and mortality, understanding how the virus interacts with the host's immune system is of great importance for generating vaccines and therapeutics. Previous work by our group identified a soluble isoform of the Lassa virus (LASV) GP1 (sGP1) <jats:italic>in vitro<\/jats:italic> resulting from the expression of the glycoprotein complex (GPC) gene [1, 2]. Though no work has directly been done to demonstrate the function of this soluble isoform in arenaviral infections, evidence points to immunomodulatory effects against the host's immune system mediated by a secreted glycoprotein component in filoviruses, another class of hemorrhagic fever-causing viruses. A significant fraction of shed glycoprotein isoforms during viral infection and biogenesis may attenuate the host's inflammatory response, thereby enhancing viral replication and tissue damage. Such shed glycoprotein mediated effects were previously reported for Ebola virus (EBOV), a filovirus that also causes hemorrhagic fever with nearly 90% fatality rates [3\u20135]. The identification of an analogous phenomenon <jats:italic>in vivo<\/jats:italic> could establish a new correlate of LHF infection leading to the development of sensitive diagnostics targeting the earliest molecular events of the disease. Additionally, the reversal of potentially untoward immunomodulatory functions mediated by sGP1 could potentiate the development of novel therapeutic intervention. To this end, we investigated the presence of sGP1 in the serum of suspected LASV patients admitted to the Kenema Government Hospital (KGH) Lassa Fever Ward (LFW), in Kenema, Sierra Leone that tested positive for viral antigen or displayed classical signs of Lassa fever.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>It is reasonable to expect that a narrow window exists for detection of sGP1 as the sole protein shed during early arenaviral biogenesis. This phenomenon was clearly distinguishable from virion-associated GP1 only prior to the emergence of <jats:italic>de novo<\/jats:italic> viral particles. Despite this restricted time frame, in 2\/46 suspected cases in two studies performed in late 2009 and early 2010, soluble glycoprotein component shedding was identified. Differential detection of viral antigens GP1, GP2, and NP by western blot yielded five different scenarios: whole LASV virions (GP1, GP2, NP; i.e. active viremia), different combinations of these three proteins, sGP1 only, NP only, and absence of all three proteins. Four additional samples showed inconclusive evidence for sGP1 shedding due to lack of detection of GP2 and NP by western blot; however, a sensitive LASV NP antigen capture ELISA generated marginally positive signals<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>During a narrow window following active infection with LASV, soluble GP1 can be detected in patient sera. This phenomenon parallels other VHF infection profiles, with the actual role of a soluble viral glycoprotein component <jats:italic>in vivo<\/jats:italic> remaining largely speculative. The expenditure of energy and cellular resources toward secretion of a critical protein during viral biogenesis without apparent specific function requires further investigation. Future studies will be aimed at systematically identifying the role of LASV sGP1 in the infection process and outcome <jats:italic>in vitro<\/jats:italic> and <jats:italic>in vivo<\/jats:italic>.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1743-422x-7-306","type":"journal-article","created":{"date-parts":[[2010,11,10]],"date-time":"2010-11-10T07:19:03Z","timestamp":1289373543000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Shedding of soluble glycoprotein 1 detected during acute Lassa virus infection in human subjects"],"prefix":"10.1186","volume":"7","author":[{"given":"Luis M","family":"Branco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica N","family":"Grove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina M","family":"Moses","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augustine","family":"Goba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Fullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mambu","family":"Momoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randal J","family":"Schoepp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel G","family":"Bausch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert F","family":"Garry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,11,9]]},"reference":[{"key":"1050_CR1","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/1743-422X-5-161","volume":"5","author":"MM Illick","year":"2008","unstructured":"Illick MM, Branco LM, Fair JN, Illick KA, Matschiner A, Schoepp R, Garry RF, Guttieri MC: Uncoupling GP1 and GP2 expression in the Lassa virus glycoprotein complex: implications for GP1 ectodomain shedding. Virology J 2008, 5: 161. 10.1186\/1743-422X-5-161","journal-title":"Virology J"},{"key":"1050_CR2","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/1743-422X-6-147","volume":"6","author":"LM Branco","year":"2009","unstructured":"Branco LM, Garry RF: Characterization of the Lassa virus GP1 ectodomain shedding: implications for improved diagnostic platforms. Virology J 2009, 6: 147. 10.1186\/1743-422X-6-147","journal-title":"Virology J"},{"key":"1050_CR3","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1038\/sj.emboj.7600219","volume":"23","author":"O Dolnik","year":"2004","unstructured":"Dolnik O, Volchkova V, Garten W, Carbonnelle C, Becker S, Kahnt J, Str\u00f6her U, Klenk HD, Volchkov V: Ectodomain shedding of the glycoprotein GP of Ebola virus. The EMBO J 2004, 23: 2175-2184. 10.1038\/sj.emboj.7600219","journal-title":"The EMBO J"},{"issue":"4","key":"1050_CR4","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1128\/JVI.79.4.2413-2419.2005","volume":"79","author":"V Wahl-Jensen","year":"2005","unstructured":"Wahl-Jensen V, Kurz SK, Hazelton PR, Schnittler HJ, Str\u00f6her U, Burton DR, Feldmann H: Role of Ebola virus secreted glycoproteins and virus-like particles in activation of human macrophages. J Virol 2005,79(4):2413-2419. 10.1128\/JVI.79.4.2413-2419.2005","journal-title":"J Virol"},{"issue":"16","key":"1050_CR5","doi-asserted-by":"publisher","first-page":"10442","DOI":"10.1128\/JVI.79.16.10442-10450.2005","volume":"79","author":"VM Wahl-Jensen","year":"2005","unstructured":"Wahl-Jensen VM, Afanasieva TA, Seebach J, Str\u00f6her U, Feldmann H, Schnittler HJ: Effects of Ebola virus glycoproteins on endothelial cell activation and barrier function. J Virol 2005,79(16):10442-10450. 10.1128\/JVI.79.16.10442-10450.2005","journal-title":"J Virol"},{"key":"1050_CR6","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1586\/14760584.3.2.189","volume":"3","author":"SP Fisher-Hoch","year":"2004","unstructured":"Fisher-Hoch SP, McCormick JB: Lassa fever vaccine: A review. Expert Rev Vaccines 2004, 3: 103-111. 10.1586\/14760584.3.2.189","journal-title":"Expert Rev Vaccines"},{"key":"1050_CR7","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/BF02122438","volume":"175","author":"JB McCormick","year":"1986","unstructured":"McCormick JB: Clinical, epidemiologic, and therapeutic aspects of Lassa fever. Med Microbiol Immunol 1986, 175: 153-155. 10.1007\/BF02122438","journal-title":"Med Microbiol Immunol"},{"key":"1050_CR8","first-page":"69","volume":"134","author":"JB McCormick","year":"1987","unstructured":"McCormick JB: Epidemiology and control of Lassa fever. Current Topics in Microbiol and Immunol 1987, 134: 69-78.","journal-title":"Current Topics in Microbiol and Immunol"},{"key":"1050_CR9","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1136\/bmj.311.7009.857","volume":"311","author":"SP Fisher-Hoch","year":"1995","unstructured":"Fisher-Hoch SP, Tomori O, Nasidi A, Perez-Oronoz GI, Fakile Y, Hutwagner L, McCormick JB: Review of cases of nosocomial Lassa fever in Nigeria: the high price of poor medical practice. Br Med J 1995, 311: 857-859.","journal-title":"Br Med J"},{"key":"1050_CR10","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1093\/infdis\/155.3.437","volume":"155","author":"JB McCormick","year":"1987","unstructured":"McCormick JB, Webb PA, Krebs JW, Johnson KMES, Smith ES: A prospective study of the epidemiology and ecology of Lassa fever. J Infect Dis 1987, 155: 437-444.","journal-title":"J Infect Dis"},{"key":"1050_CR11","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1056\/NEJM198601023140104","volume":"314","author":"JB McCormick","year":"1986","unstructured":"McCormick JB, King IJ, Webb PA, Scribner CL, Craven RB, Johnson KM, Elliot LH, Belmont-Williams R: Lassa fever. Effective therapy with ribavirin. N Engl J Med 1986, 314: 20-26. 10.1056\/NEJM198601023140104","journal-title":"N Engl J Med"},{"key":"1050_CR12","first-page":"1635","volume-title":"Fields Virology","author":"MJ Buchmeier","year":"2001","unstructured":"Buchmeier MJ, Bowen MD, Peters CJ: Arenaviridae: The viruses and their replication. In Fields Virology. 4th edition. Edited by: Knipe DM, Howley PM. Philadelphia: Lippincott-Raven; 2001:1635-1668.","edition":"4"},{"key":"1050_CR13","doi-asserted-by":"publisher","first-page":"12701","DOI":"10.1073\/pnas.221447598","volume":"A98","author":"O Lenz","year":"2001","unstructured":"Lenz O, ter Meulen J, Klenk HD, Seidah NG, Garten W: The Lassa virus glycoprotein precursor GP-C is proteolytically processed by subtilase SKI-1\/S1P. Proc Natl Acad Sci USA 2001, A98: 12701-12705. 10.1073\/pnas.221447598","journal-title":"Proc Natl Acad Sci USA"},{"key":"1050_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2180-1-1","volume":"1","author":"WR Gallaher","year":"2001","unstructured":"Gallaher WR, DiSimone C, Buchmeier MJ: The viral transmembrane superfamily: Possible divergence of arenavirus and filovirus glycoproteins from a common RNA virus ancestor. BMC Microbiol 2001, 1: 1. 10.1186\/1471-2180-1-1","journal-title":"BMC Microbiol"},{"key":"1050_CR15","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1099\/0022-1317-64-5-1127","volume":"64","author":"JC Clegg","year":"1983","unstructured":"Clegg JC, Lloyd G: Structural and cell-associated proteins of Lassa virus. J Gen Virol 1983, 64: 1127-1136. 10.1099\/0022-1317-64-5-1127","journal-title":"J Gen Virol"},{"key":"1050_CR16","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1099\/0022-1317-68-9-2465","volume":"68","author":"PR Young","year":"1987","unstructured":"Young PR, Chanas AC, Lee SR, Gould EA, Howard CR: Localization of an arenavirus protein in the nuclei of infected cells. J Gen Virol 1987, 68: 2465-2470. 10.1099\/0022-1317-68-9-2465","journal-title":"J Gen Virol"},{"key":"1050_CR17","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/BF01313953","volume":"106","author":"FT Hufert","year":"1989","unstructured":"Hufert FT, Ludke W, Schmitz H: Epitope mapping of the Lassa virus nucleoprotein using monoclonal anti-nucleocapsid antibodies. Arch Virol 1989, 106: 201-212. 10.1007\/BF01313953","journal-title":"Arch Virol"},{"issue":"22","key":"1050_CR18","doi-asserted-by":"publisher","first-page":"12978","DOI":"10.1073\/pnas.2133782100","volume":"100","author":"M Perez","year":"2003","unstructured":"Perez M, Craven RC, de la Torre JC: The small RING finger protein Z drives arenavirus budding: implications for antiviral strategies. Proc Natl Acad Sci USA 2003,100(22):12978-12983. 10.1073\/pnas.2133782100","journal-title":"Proc Natl Acad Sci USA"},{"issue":"19","key":"1050_CR19","doi-asserted-by":"publisher","first-page":"10700","DOI":"10.1128\/JVI.77.19.10700-10705.2003","volume":"77","author":"T Strecker","year":"2003","unstructured":"Strecker T, Eichler R, Meulen J, Weissenhorn W, Dieter Klenk H, Garten W, Lenz O: Lassa virus Z protein is a matrix protein and sufficient for the release of virus-like particles. J Virol 2003,77(19):10700-10705. 10.1128\/JVI.77.19.10700-10705.2003","journal-title":"J Virol"},{"issue":"2","key":"1050_CR20","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.virusres.2003.11.017","volume":"100","author":"R Eichler","year":"2004","unstructured":"Eichler R, Strecker T, Kolesnikova L, ter Meulen J, Weissenhorn W, Becker S, Klenk HD, Garten W, Lenz O: Characterization of the Lassa virus matrix protein Z: electron microscopic study of virus-like particles and interaction with the nucleoprotein (NP). Virus Res 2004,100(2):249-255. 10.1016\/j.virusres.2003.11.017","journal-title":"Virus Res"},{"key":"1050_CR21","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/1743-422X-3-93","volume":"3","author":"T Strecker","year":"2006","unstructured":"Strecker T, Maisa A, Daffis S, Eichler R, Lenz O, Garten W: The role of myristoylation in the membrane association of the Lassa virus matrix protein Z. Virol J 2006, 3: 93. 10.1186\/1743-422X-3-93","journal-title":"Virol J"},{"issue":"7","key":"1050_CR22","doi-asserted-by":"publisher","first-page":"3178","DOI":"10.1128\/JVI.02240-09","volume":"84","author":"K Schlie","year":"2010","unstructured":"Schlie K, Maisa A, Freiberg F, Groseth A, Strecker T, Garten W: Viral protein determinants of Lassa virus entry and release from polarized epithelial cells. J Virol 2010,84(7):3178-3188. 10.1128\/JVI.02240-09","journal-title":"J Virol"},{"key":"1050_CR23","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1099\/0022-1317-72-3-549","volume":"72","author":"SL Ruo","year":"1991","unstructured":"Ruo SL, Mitchell SW, Killey MP, Roumillat LF, Fisher-Hoch SP, McCormick JB: Antigenic relatedness between arenaviruses defined at the epitope level by monoclonal antibodies. J Gen Virol 1991, 72: 549-555. 10.1099\/0022-1317-72-3-549","journal-title":"J Gen Virol"},{"key":"1050_CR24","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1128\/JCM.38.7.2670-2677.2000","volume":"38","author":"DG Bausch","year":"2000","unstructured":"Bausch DG, Rollin PE, Demby AH, Coulibaly M, Kanu J, Conteh AS, Wagoner KD, McMullan LK, Bowen MD, Peters CJ, Ksiazek T: Diagnosis and clinical virology of Lassa fever as evaluated by enzyme-linked immunosorbent assay, indirect fluorescent-antibody test, and virus isolation. J Clin Microbiol 2000, 38: 2670-2677.","journal-title":"J Clin Microbiol"},{"key":"1050_CR25","first-page":"1","volume-title":"A clinical guide to viral haemorrhagic fever: Ebola, Marburg, and Lassa. Trop Doct","author":"B Jeffs","year":"2006","unstructured":"Jeffs B: A clinical guide to viral haemorrhagic fever: Ebola, Marburg, and Lassa. Trop Doct. 2006,36(1):1-14."},{"key":"1050_CR26","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/1743-422X-7-279","volume":"7","author":"LM Branco","year":"2010","unstructured":"Branco LM, Grove JN, Geske FJ, Boisen ML, Muncy IJ, Magliato SA, Henderson LA, Schoepp RJ, Cashman KA, Hensley LE, Garry RF: Lassa virus-like particles displaying all major immunological determinants as a vaccine candidate for Lassa hemorrhagic fever. Virology J 2010, 7: 279. 10.1186\/1743-422X-7-279","journal-title":"Virology J"},{"issue":"24","key":"1050_CR27","doi-asserted-by":"publisher","first-page":"12191","DOI":"10.1128\/JVI.01604-08","volume":"82","author":"A Bukreyev","year":"2008","unstructured":"Bukreyev A, Yang L, Fricke J, Cheng L, Ward JM, Murphy BR, Collins PL: The Secreted Form of Respiratory Syncytial Virus G Glycoprotein Helps the Virus Evade Antibody-Mediated Restriction of Replication by Acting as an Antigen decoy and through Effects on Fc Receptor-Bearing Leukocytes. J Virol 2008,82(24):12191-12204. 10.1128\/JVI.01604-08","journal-title":"J Virol"},{"issue":"22","key":"1050_CR28","doi-asserted-by":"publisher","first-page":"12701","DOI":"10.1073\/pnas.221447598","volume":"98","author":"O Lenz","year":"2001","unstructured":"Lenz O, ter Meulen J, Klenk HD, Seidah NG, Garten W: The Lassa virus glycoprotein precursor GP-C is proteolytically processed by subtilase SKI-1\/S1P. Proc Natl Acad Sci USA 2001,98(22):12701-12705. 10.1073\/pnas.221447598","journal-title":"Proc Natl Acad Sci USA"},{"key":"1050_CR29","doi-asserted-by":"crossref","unstructured":"Urata S, Noda T, Kawaoka Y, Yokosawa H, Yasuda J: Cellular factors required for Lassa virus budding. J Virol 2006, (8):4191-4195. 10.1128\/JVI.80.8.4191-4195.2006","DOI":"10.1128\/JVI.80.8.4191-4195.2006"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1743-422X-7-306.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T12:19:35Z","timestamp":1630498775000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/1743-422X-7-306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,9]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["1050"],"URL":"https:\/\/doi.org\/10.1186\/1743-422x-7-306","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,9]]},"assertion":[{"value":"26 September 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2010","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2010","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"306"}}